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        Introduction 
  Blood vessel formation is a fundamental process in organo-
genesis during embryonic development (  Coultas et al., 2005  ; 
  Ferguson et al., 2005  ). Vascular progenitor cells are thought to 
fi  rst appear in the posterior primitive streak as vascular endo-
thelial growth factor receptor 2  –  positive (VEGFR2 
+ )  meso-
dermal cells. These cells are specifi  ed for the hematopoietic 
and/or vascular lineage (hemangioblasts or angioblasts) and 
then migrate into extraembryonic sites, including the yolk sac 
and allantois as well as intraembryonic sites, in VEGF-A  – 
dependent fashion (  Huber et al., 2004  ;   Hiratsuka et al., 2005  ). 
These precursor cells differentiate and assemble to form pri-
mary capillary plexuses or directly aggregate into the dorsal aorta 
or cardinal vein, followed by a process of remodeling through 
sprouting/nonsprouting angiogenesis and fusion of vessels. 
Finally, maturation of the nascent vasculature is accom-
plished by recruitment and adhesion of mural cells to endo-
thelial cells. 
  VEGFR2 (also known as Flk1 and KDR), one of the 
receptors for the VEGF family of growth factors, plays essential 
roles during vascular development. VEGFR2-defi  cient mice die 
in utero between 8.5 and 9.5 d postcoitum because of lack of 
endothelial cells and hematopoietic cells (  Shalaby et al., 1995  ). 
Subsequent analysis suggested that the role of VEGFR2 signal-
ing in vascular development in vivo includes proliferation, mi-
gration, and differentiation of progenitor cells (  Shalaby et al., 
1997 ).  Because  VEGFR2 
+   mesodermal cells can give rise to 
multiple lineages other than endothelial and hematopoietic cells, 
including vascular mural cells, skeletal muscle cells, and cardio-
myocytes (  Motoike et al., 2003  ;   Ema et al., 2006 ),  differentiation 
of VEGFR2 
+   cells should be appropriately specifi  ed. However, 
the signal transduction pathways leading to endothelial specifi  -
cation downstream of VEGFR2 are poorly understood, al-
though those for cell proliferation and migration have been well 
explored in mature endothelial cells (  Shibuya and Claesson-
Welsh, 2006  ). 
V
ascular endothelial growth factor receptor 2 
(VEGFR2) transmits signals of crucial importance 
to vasculogenesis, including proliferation, mi-
gration, and differentiation of vascular progenitor cells. 
Embryonic stem cell  –  derived VEGFR2 
+   mesodermal cells 
differentiate into mural lineage in the presence of platelet 
derived growth factor (PDGF)  –  BB or serum but into endo-
thelial lineage in response to VEGF-A. We found that in-
hibition of H-Ras function by a farnesyltransferase inhibitor 
or a knockdown technique results in selective suppression 
of VEGF-A  –  induced endothelial speciﬁ  cation. Experiments 
with ex vivo whole-embryo culture as well as analysis of 
H-  ras   
    /      mice also supported this conclusion. Further-
more, expression of a constitutively active H-Ras[G12V] 
in VEGFR2 
+   progenitor cells resulted in endothelial differ-
entiation through the extracellular signal-related kinase 
(Erk) pathway. Both VEGF-A and PDGF-BB activated Ras 
in VEGFR2 
+   progenitor cells 5 min after treatment. How-
ever, VEGF-A, but not PDGF-BB, activated Ras 6  –  9 h after 
treatment, preceding the induction of endothelial markers. 
VEGF-A thus activates temporally distinct Ras  –  Erk signal-
ing to direct endothelial speciﬁ  cation of VEGFR2 
+   vascu-
lar progenitor cells.
  Ras signaling directs endothelial speciﬁ  cation 
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stimulation with VEGF-A increased PECAM1 
+   colonies and 
decreased    SMA 
+   colonies, indicating that VEGF-A directs 
endothelial differentiation at the expense of mural differentia-
tion. In the presence of FTI-277, the number of PECAM1 
+  
colonies was decreased and that of    SMA 
+   colonies was in-
creased, whereas the total number of colonies was not markedly 
changed. These fi  ndings indicate that FTI-277 specifi  cally in-
hibits endothelial differentiation of ESC-derived VEGFR2 
+  
cells. Similar results were obtained using MGZ5 ESCs (un-
published data). 
  To determine when FTI-277  –  sensitive signal is transmit-
ted, we added FTI-277 at different time points after VEGF-A 
stimulation (  Fig. 1 C  ). When FTI-277 was added 3 h after 
stimu  lation, the appearance of PECAM1 
+   cells was sup-
pressed but when FTI-277 was added 6 h after stimulation, it 
was not. We concluded that the FTI-277  –  sensitive signal for 
endothelial specifi  cation is transmitted later than 3 h after 
VEGF-A stimulation. 
  We also performed ex vivo whole-embryo culture assay to 
investigate the effects of FTI-277 on vascular development in 
mouse embryo. Embryonic day (E)  –  6.75 concepti were picked 
out from the uteri of pregnant mice and cultured for 3 d, during 
which PECAM1 
+   blood vessels were formed in the yolk sac. 
In the presence of FTI-277, however, PECAM1 
+   vessels were 
diminished, although overall development of the yolk sac was 
not affected (  Fig. 1 D  ). We then examined the expression of 
vascular markers by quantitative RT-PCR. FTI-277 treatment 
resulted in decrease in the level of expression of PECAM1 and 
VE-cadherin compared with control, whereas expression of   SMA 
was unchanged (  Fig. 1 E  ). These fi  ndings suggest that FTI-277 
suppresses vascular development. 
  Loss of H-Ras abrogates endothelial 
differentiation of VEGFR2 
+   cells 
  Because the principal targets of FTI-277 include H-Ras, it ap-
peared possible that Ras signaling could be involved in VEGF-A  –
  induced endothelial differentiation of vascular progenitor cells. 
To examine the effect of H-Ras inactivation on vascular 
development, we investigated the vascular phenotype of H-  ras  
knockout mice. Heterozygous H-  ras  
+/      mice  produced  homo-
zygous H-  ras  
   /     offspring in Mendelian ratio (+/+, 17; +/   , 
36; and    /   , 17), as described previously (  Ise et al., 2000  ; 
  Esteban et al., 2001  ). We therefore focused on vascular pheno-
types during early development, and found vascular aberration 
in the periphery of the brain of 73% (8/11) of H-  ras  
   /     em-
bryos studied at E9.5, although they contained similar num-
bers of somites, as did wild-type and heterozygous littermates 
( Fig.  2 A ).  H- ras  
+/      embryos exhibited no clear difference from 
wild-type embryos. We further double stained the cephalic re-
gion for PECAM1 and VEGFR2, the earliest marker of differ-
entiation of endothelial cells (  Fig. 2 B  ). In H-  ras  
+/      embryos, 
complex vascular networks were stained for both PECAM1 
and VEGFR2, whereas in H-  ras  
   /     embryos, vascular struc-
tures positive for either PECAM1 or VEGFR2 were strik-
ingly reduced. Furthermore, we found that vascular structures 
were rare in cross sections of the head region of H-  ras  
   /    
embryos (  Fig. 2 C  ). This vascular aberration was transient, 
  Use of differentiating embryonic stem cells (ESCs) is ad-
vantageous for the study of signaling for lineage specifi  cation 
because migration of progenitor cells to the correct microenviron-
ment is unnecessary. Using mouse ESC-derived VEGFR2 
+  
cells, an in vitro system for analysis of ligand-dependent endo-
thelial specifi  cation has recently been established (  Hirashima 
et al., 1999  ;   Yamashita et al., 2000  ). In this system, ESC-derived 
VEGFR2 
+   cells differentiate into endothelial cells in response 
to VEGF-A, whereas they differentiate into     – smooth  muscle 
actin – positive (  SMA 
+ ) mural cells resembling vascular smooth 
muscle cells in the presence of PDGF-BB or serum (  Yamashita 
et al., 2000  ;   Ema et al., 2003  ;   Watabe et al., 2003  ). VEGFR2 
  appears to transmit a specifi  c signal for induction of endothelial 
differentiation of VEGFR2 
+   progenitor cells because signaling 
from either VEGFR1 or 3 fails to induce it (  Yamashita et al., 2000 ; 
  Suzuki et al., 2005  ). 
  In the present study, we investigated the signaling pathway 
downstream of VEGFR2 for specifi  cation of endothelial lineage. 
Using pharmacological inhibitors, a gene silencing approach, 
and a gain-of-function approach, we concluded that Ras signal-
ing is involved in endothelial specifi  cation induced by VEGF-A. 
Although PDGF-BB fails to induce endothelial differentiation, 
it also activates Ras in VEGFR2 
+   progenitor cells. We found that 
VEGF-A activates the Ras pathway at periods distinct from 
PDGF-BB, thus directing endothelial differentiation from 
VEGFR2 
+   vascular progenitor cells. These fi  ndings also provide 
mechanistic insights into signaling for cell specifi  cation through 
widely shared effector molecules. 
  Results 
  A farnesyltransferase inhibitor, FTI-277, 
inhibits VEGF-A  –  induced endothelial 
speciﬁ  cation of ESC-derived VEGFR2 
+   cells 
  To determine the signaling components required for VEGF-A  –
  induced endothelial differentiation from vascular progenitor 
cells, we used in vitro vascular differentiation systems ( Yamashita 
et al., 2000  ). VEGFR2 
+   cells derived from CCE mouse ESCs 
were cultured in medium containing serum with or without 
VEGF-A. In the absence of VEGF-A, most cells differentiated into 
   SMA 
+   mural cells, whereas in the presence of VEGF-A, platelet-
endothelial cell adhesion molecule-1  –  positive (PECAM1 
+ )  endo-
thelial cells emerged (  Fig. 1 A  ;   Yamashita et al., 2000  ). 
 We  fi rst examined the effects of various inhibitors target-
ing signal molecules. Among those tested, we found that FTI-
277 (  Lerner et al., 1995  ), a farnesyltransferase inhibitor, had a 
selective inhibitory effect on endothelial differentiation. When 
FTI-277 was added, VEGF-A  –  induced appearance of PECAM1 
+  
cells was suppressed, whereas that of    SMA 
+   cells was not 
markedly altered (  Fig. 1 A  ). To determine whether the reduction 
in number of PECAM1 
+   cells by FTI-277 was caused by inhibi-
tion of differentiation, we next performed quantitative analyses 
using a limiting dilution assay (  Fig. 1 B  ). When VEGFR2 
+   cells 
were seeded at low density (90  –  120 cells/cm 
2  ), they formed 
single-cell  –  derived colonies in 4 d. We counted the number of 
colonies after immunostaining for PECAM1 and    SMA,  which 
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down condition), VEGF-A  –  induced PECAM1 
+   colonies  decreased 
in number, whereas    SMA 
+   colonies increased compared with 
those in the presence of Tc (  Fig. 2 D  ). In Tc-miR-NTC cells ex-
pressing negative control miRNA, PECAM1 
+   colonies did not 
decrease in number (unpublished data). These fi  ndings suggest 
that H-Ras plays a role in endothelial specifi  cation of VEGFR2 
+  
progenitor cells. 
  Constitutively active G12V mutant of 
H-Ras induces PECAM1 
+   cells from 
VEGFR2 
+   progenitor cells 
  We next established ESC lines carrying a Tc-regulatable active 
form of H-Ras (Tc-H-Ras[G12V]) or no transgene (Tc-empty). 
In Tc-H-Ras[G12V] cells, Ras is expressed at high levels in 
the absence of Tc but is not expressed in the presence of Tc 
(Fig. S2, available at http://www.jcb.org/cgi/content/full/jcb
.200709127/DC1). We then examined differentiation of VEGFR2 
+  
and no obvious abnormality was observed in E10.5 H-  ras  
   /    
embryos (unpublished data). 
  To determine whether H-Ras regulates endothelial differ-
entiation from vascular progenitor cells in vitro, we established 
stable ESC lines in which expression of H-Ras can be knocked 
down by microRNA (miRNA) under the control of tetracycline 
(Tc) because siRNA duplex was only minimally incorporated 
into ESC-derived VEGFR2 
+   cells. A premiRNA sequence tar-
geting H-Ras was knocked into the   ROSA26   locus in MGZ-
RTcH cells (Tc-miR-H-Ras; Fig. S1 A, available at http://www
.jcb.org/cgi/content/full/jcb.200709127/DC1). In MGZRTcH 
cells, expression of transgene at the   ROSA26   locus was induced 
by removal of Tc (  Masui et al., 2005  ). In Tc-miR-H-Ras cells, 
expression of endogenous H-Ras was knocked down in the 
absence of Tc (Fig. S1 B). Limiting dilution assay was then 
performed  for  Tc-miR-H-Ras – derived  VEGFR2 
+   cells in the 
presence or absence of Tc. In the absence of Tc (Ras  –  knocked 
  Figure 1.       Inhibitory effect of FTI-277 on 
endothelial differentiation.   (A) ESC-derived 
VEGFR2 
+   cells were cultured for 2 d with 1   μ  M 
FTI-277 and/or 30 ng/ml VEGF-A, followed 
by immunostaining for PECAM1 (green), 
    SMA (red), and nuclei (blue). Bars, 100   μ  m. 
(B) Quantiﬁ  cation of colony formation. FTI-277 
was used at 3   μ  M. Representative results for 
three independent experiments are shown. 
(C) Time course of changes in FTI-277 sensitivity 
of VEGF-A-dependent endothelial differentiation. 
1   μ  M FTI-277 was added at 0, 3, and 6 h af-
ter stimulation with VEGF-A, and cultured until 
48 h. Cells were immunostained for PECAM1 
(green),     SMA (red), and nuclei (blue). Bars, 
100   μ  m. Quantiﬁ   cation of appearance of 
PECAM1 
+   cells is indicated below the pan-
els (% of PECAM1 
+   cells; means   ±   SD from 
three independent ﬁ   elds). (D) Ex vivo culture 
of mouse embryo E6.75 concepti were picked 
out and cultured with or without 10   μ  M FTI-
277 for 3 d. Vasculature in yolk sacs of con-
cepti were immunostained for PECAM1 (blue). 
Bars, 1 mm. (E) Quantitative RT-PCR analysis of 
PECAM1, VE-cadherin, and     SMA of ex vivo  –
  cultured whole concepti. Each value is normal-
ized to expression of     -actin. Values are the 
means   ±   SD of triplicate measurements. *, P   <   
0.02 (Student  ’  s   t   test).     JCB • VOLUME 181 • NUMBER 1 • 2008  134 
were cultured in type I collagen gel for 7 d. When active Ras was 
inducibly expressed, cells formed tube-like structures even in the 
absence of VEGF-A ( Fig. 3 D ). Furthermore, we performed in vivo 
vascular formation assay. Tc-empty and Tc-H-Ras[G12V] cells 
were labeled with retrovirus carrying YFP. These cells were differ-
entiated in vitro and subcutaneously injected, together with Matri-
gel, into the abdominal region of mice. After 10 d, Matrigel was 
harvested, frozen sectioned, and immunostained for PECAM1 and 
    SMA. When Tc-H-Ras[G12V] cells were injected, PECAM1 
+  
blood vessels surrounded by    SMA 
+   cells were observed. These 
PECAM1 
+   cells were also positive for YFP, indicating that they 
originated from Tc-H-Ras[G12V] cells (  Fig. 3 E  ). In contrast, 
PECAM1 
+  vessels were not observed when Tc-H-Ras[G12V] cells 
were injected, but H-Ras[G12V] expression was suppressed by 
treatment with Tc or when Tc-empty cells were injected. These 
fi  ndings suggest that active Ras induces differentiation of cells with 
characteristics of endothelial cells from VEGFR2 
+   progenitor  cells. 
cells derived from these cell lines. When H-Ras[G12V] was not 
expressed in the presence of Tc, appearance of PECAM1 
+   cells 
was  VEGF-A – dependent  ( Fig.  3  A ,  H-Ras[G12V](-)).  Upon  ex-
pression of H-Ras[G12V] by removal of Tc, PECAM1 
+   cells  ap-
peared even in the absence of VEGF-A ( Fig. 3 A , H-Ras[G12V] (+)). 
Among Tc-empty cells, PECAM1 
+   cells were not induced by 
removal of Tc (unpublished data). We further confi  rmed that the 
appearance of PECAM1 
+   cells induced by H-Ras[G12V] was in-
hibited by FTI-277 (Fig. S3 A). 
 These  PECAM1 
+   cells were also positive for other endo-
thelial markers, including VE-cadherin (  Fig. 3 B  ), CD34, and en-
doglin (not depicted), and they incorporated acetylated low-density 
lipoprotein (AcLDL;   Fig. 3 C  ) and expressed mRNA for endo-
thelial nitric oxide synthase and claudin-5 (not depicted). We next 
examined the ability of VEGFR2 
+   cells to form vascular structures 
in three-dimensional culture upon expression of H-Ras[G12V]. 
Aggregated VEGFR2 
+   cells derived from Tc-H-Ras[G12V] cells 
  Figure 2.       Loss of H-Ras impairs vascular development.   
(A) Whole-mount PECAM1 staining of E9.5 H-  ras   
+/       
and H-  ras   
    /      mice. Magniﬁ   cations of the areas 
marked with arrows in the top are shown in the 
bottom. (B) Immunostaining for PECAM1 (green), 
VEGFR2 (red), and     -catenin (blue) of cephalic region 
of E9.5 H-  ras   
+/      and H-  ras   
    /      mice. Bars, 100   μ  m. 
(C) Immunostaining for PECAM1 (green) of cross sec-
tions of cephalic region of E9.5 H  -ras   
+/      and H-  ras   
    /      
mice. Magniﬁ  cations of the boxed areas in the left are 
shown in the right. Bars: (left) 100   μ  m; (right) 20   μ  m. 
(D) Quantiﬁ   cation of colony formation of Tc-miR-H-
Ras cells, in which H-Ras has been knocked down by 
miRNA in the absence of Tc. Representative results of 
three independent experiments are shown.     135  RAS SIGNALING IN ENDOTHELIAL SPECIFICATION   •   KAWASAKI ET AL.
H-Ras[G12V] directed differentiation of VEGFR2 
+   progenitor 
cells to PECAM1 
+   cells in the present experimental system. 
To exclude this possibility, we examined Ras-induced endothelial 
differentiation in the presence of SU5614 (  Spiekermann et al., 
2002  ), an inhibitor of VEGFR2 kinase, as well as VEGFR1 (Flt1)-
Fc chimera protein, which competes with VEGFR2 for binding 
with VEGF-A. Ras-induced endothelial differentiation was not 
inhibited under these conditions (Fig. S3 B and not depicted). 
Furthermore, Ras-induced endothelial cells formed tube-like 
structure in the presence of SU5614 (Fig. S3 C). These fi  ndings 
suggest that differentiation depends primarily on intracellular 
signal transduction from Ras protein. 
  We next established ESC lines in which H-Ras effector mu-
tants H-Ras[G12V, T35S] or H-Ras[G12V, Y40C] can be inducibly 
expressed to examine the signaling pathway mediating Ras-induced 
endothelial specifi  cation. H-Ras[G12V, T35S] and H-Ras[G12V, 
Y40C] preferentially activate the Raf  –  MEK  –  Erk and PI3K  –  Akt 
pathways, respectively (  Joneson et al., 1996  ; Fig. S4, available 
at http://www.jcb.org/cgi/content/full/jcb.200709127/DC1). 
  Signaling for endothelial speciﬁ  cation is 
mediated through the Ras  –  Erk pathway 
  To investigate whether Ras signaling is involved in cell fate deter-
mination, we next performed a limiting dilution assay (  Fig. 4 A  ). 
When H-Ras[G12V] was expressed, the total number of colonies 
increased. PECAM1 
+   colonies dramatically increased in number. 
Notably,    SMA 
+   colonies decreased in number. These fi  ndings 
suggest that expression of active Ras leads to endothelial differ-
entiation at the expense of mural differentiation. To confi  rm the 
causal relationship between Ras expression and endothelial dif-
ferentiation, cells were immunocytochemically examined for Ras 
expression (  Fig. 4 B  ). Cells that successfully expressed Ras at 
high levels were positive for PECAM1, whereas those that failed 
to express Ras were positive for    SMA.  These  fi  ndings suggest 
that expression of constitutively active Ras directs endothelial 
specifi  cation of VEGFR2 
+   cells. 
  Ras signaling is known to induce the expression of VEGF-A 
(  Rak et al., 1995  ;   Grugel et al., 1995  ;   Arbiser et al., 1997  ). 
It thus appeared possible that VEGF-A induced by signaling from 
  Figure 3.       Induction of PECAM1 
+   cells by H-
Ras[G12V].   (A) Differentiation of VEGFR2 
+   
Tc-H-Ras[G12V] cells in which constitutively 
active form of Ras is induced. Tc-H-Ras[G12V] 
ESCs were cultured on type IV collagen-
coated dishes in the absence of LIF for 4 d 
during which expression of H-Ras[G12V] was 
suppressed by addition of Tc. ESC-derived 
VEGFR2 
+   cells were then sorted and further 
cultured for 2 d with or without 1   μ  g/ml Tc 
and/or 30 ng/ml VEGF-A, followed by im-
munostaining for PECAM1 (green),     SMA 
(red), and nuclei (blue). Bars, 100   μ  m. (B) 
Immunostaining of H-Ras[G12V]  –  induced 
PECAM1 
+   cells for VE-cadherin. PECAM1, 
green;     SMA, blue; and VE-cadherin, red. 
Bars, 100   μ  m. (C) PECAM1 staining (green) 
and AcLDL uptake (red) of PECAM1 
+   cells 
induced by H-Ras[G12V]. Bars, 50   μ  m. 
(D) Three-dimensional culture of Tc-H-Ras[G12V] 
cells. ESC-derived VEGFR2 
+   cells were cul-
tured for 12 h on Petri dishes with 1   μ  g/ml 
Tc and/or 30 ng/ml VEGF-A. Aggregates 
formed were suspended in type I collagen gel 
and cultured for 7 d in medium containing 
1   μ  g/ml Tc and/or 30 ng/ml VEGF-A, followed 
by microscopic observation. Bars, 200   μ  m. (E) 
In vivo vascular formation assay. Tc-empty and 
Tc-H-Ras[G12V] cells were labeled with retrovi-
rus encoding YFP. After in vitro differentiation, 
Tc-H-Ras[G12V] or Tc-empty cells were mixed 
with Matrigel and subcutaneously injected into 
129svJ mice. In vivo suppression of transgene 
was maintained by adding 1   μ  g/ml Tc in Matri-
gel and supplementing drinking water with 
2 mg/ml doxycycline. After 10 d, Matrigels 
containing ES-derived cells were picked out 
and frozen sectioned, followed by immuno-
staining for PECAM1 (green) and     SMA (red). 
Fluorescence of YFP is also shown (blue). +, 
transgene-induced condition (-Tc); -, transgene-
suppressed condition (+Tc). Arrows indicate 
PECAM1 
+   vessels covered with     SMA 
+   cells. 
Bars, 20   μ  m.     JCB • VOLUME 181 • NUMBER 1 • 2008  136 
appears to be different from that by PDGF receptors. In this re-
spect, it is notable that FTI-277 was still effective in inhibiting 
endothelial differentiation when added 3 h after VEGF-A stimu-
lation (  Fig. 1 C  ). The specifi  city of Ras signaling induced by 
VEGFR2 can be attributed to the timing of Ras activation. 
We therefore investigated the window of time within which Ras 
protein is specifi  cally activated by VEGF-A, focusing on the 
period more than 3 h after stimulation with VEGF-A. We fi  rst 
examined levels of phosphorylation of Erk, a downstream effec-
tor of Ras, 3  –  12 h after stimulation with VEGF-A (  Fig. 5 A  ). 
Erk phosphorylation peaked at 6 and 9 h after stimulation, sug-
gesting that Ras may be activated with a similar time course. We 
next examined activation of Ras in cells stimulated with VEGF-A 
or PDGF-BB for 6 h (  Fig. 5 B  ). Activated Ras was detected 
by pulldown assay using the Raf-Ras binding domain. We found 
that Ras activation in response to VEGF-A or PDGF-BB was 
markedly different at 6 h after stimulation. VEGF-A caused 
intense activation of Ras and Erk, whereas PDGF-BB failed 
to activate both Ras and Erk. At 5 min after stimulation with 
VEGF-A, when VEGF-A effi  ciently activates Erk ( Takahashi et al., 
1999  ;   Yashima et al., 2001  ), the levels of activation of Ras and 
We performed a limiting dilution assay using these cells. When 
H-Ras[G12V, T35S] was expressed, PECAM1 
+   colonies  in-
creased in number, whereas    SMA 
+   colo  nies decreased (  Fig. 4 C  ). 
In contrast, when H-Ras[G12V, Y40C] was expressed, numbers 
of PECAM1 
+   colonies and    SMA 
+   colonies were unchanged 
( Fig. 4 D ). Additionally, among H-Ras[G12V, T35S] cells, those 
expressing Ras at high levels all differentiated into PECAM1 
+  
cells, whereas among H-Ras[G12V, Y40C] cells, those expressing 
Ras differentiated into either PECAM1 
+   cells or    SMA 
+   cells 
(unpublished data). These fi  ndings suggest that the Ras  –  PI3K 
pathway does not affect determination of cell fate. We concluded 
that the Ras  –  Erk pathway transmits signals required to specify 
endothelial differentiation of VEGFR2 
+   progenitor cells. 
  The window of time within which Ras is 
speciﬁ  cally activated by VEGF-A 
  Ras proteins are known to be activated by various extracellular 
stimuli including cytokines and growth factors. In the present 
experimental system, ESC-derived VEGFR2 
+   cells  differentiate 
into endothelial cells upon stimulation with VEGF-A but not 
upon stimulation with PDGF-BB. Utilization of Ras by VEGFR2 
  Figure 4.       Induction of endothelial differentiation by 
Ras  –  Erk signaling.   (A) Quantiﬁ  cation of colony forma-
tion of Tc-H-Ras[G12V] cells. Representative results of 
three independent experiments are shown. (B) Cells 
overexpressing Ras were positive for PECAM1. ESC-
derived VEGFR2 
+   cells were cultured for 2 d in the 
absence of Tc and VEGF-A, followed by immuno-
staining for PECAM1 (green),     SMA (red), and Ras 
(blue). Bars, 100   μ  m. (C and D) Quantiﬁ  cation  of 
colony formation of Tc-H-Ras[G12V, T35S] (C) and Tc-
H-Ras[G12V, Y40C] (D) cells. Representative results of 
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markers PECAM1 and VE-cadherin began to increase from 
12 h after stimulation with VEGF-A. Interestingly, the level 
of expression of VEGFR2 in VEGF-A  –  stimulated cells was 
similar to that in unstimulated cells up to 6 h after stimulation. 
During the period beyond 12 h after stimulation, VEGFR2 
expression increased in VEGF-A  –  stimulated cells, whereas 
it decreased in nonstimulated cells. These fi  ndings suggest 
that endothelial specifi  cation occurs between 6 and 12 h af-
ter stimulation with VEGF-A, which is preceded by VEGF-A  – 
induced Ras activation. Consistent with these findings, the 
level of expression of     SMA, a mural cell marker, began to in-
crease later than 24 h. Genes up-regulated at 48 h after VEGF-A 
stimulation were analyzed by oligonucleotide microarray (Af-
fymetrix) and listed in Table S1 (available at http://www.jcb
.org/cgi/content/full/jcb.200709127/DC1). We observed induc-
tion of PECAM1 and VE-cadherin, as well as VEGFR2, e-NOS, 
Tie1, and other genes expressed in endothelial cells by treat-
ment with VEGF-A. 
  We further determined expression of vascular markers after 
induction of H-Ras[G12V] (  Fig. 6 B  ). mRNA for H-Ras[G12V] 
was detected at 3  –  6 h, followed by induction of PECAM1 and 
VE-cadherin later than 12 h. Earlier induction of these endothelial 
markers may be caused by the earlier onset of Ras signaling 
through expression of the constitutively active form. Up-regulation 
of VEGFR2 was, however, delayed. The reason for this delay 
remains to be elucidated. 
  We conclude that VEGF-A stimulation of VEGFR2 
+   vas-
cular progenitor cells specifi  cally induces Ras  –  Erk activation 
around 6  –  9 h after stimulation, which in turn specifi  es endo-
thelial differentiation. 
  Discussion 
  The development of multicellular organisms requires the or-
chestrated growth, migration, and differentiation of numerous 
cells. Various extracellular factors, as well as intracellular signaling 
molecules, are involved in the robust regulation of the behaviors 
Erk were not notably different from those induced by PDGF-
BB (  Fig. 5 B  ). Activation of Ras and Erk by VEGF-A was also 
observed at 9 h but not at 3 h (unpublished data). 
  We next compared phosphorylation of Erk 3  –  12 h after 
stimulation with VEGF-A, PDGF-BB, FGF-2, and PlGF 
(Fig. S5 A, available at http://www.jcb.org/cgi/content/full/
jcb.200709127/DC1). Two ligands, PDGF-BB and PlGF, which 
lack ability to induce endothelial differentiation of VEGFR2 
+  
progenitor cells (  Yamashita et al., 2000  ), failed to activate Erk 
during the period. FGF-2 that modestly supports endothelial 
differentiation of VEGFR2 
+   progenitor cells (  Kano et al., 2005  ), 
however, resulted in strong and sustained activation of Erk from 
3 to 9 h after stimulation. These fi  ndings indicate that activation 
of Erk at late time points is specifi  c for ligands that induce endo-
thelial differentiation of VEGFR2 
+   vascular progenitor cells. 
We also examined time course of phosphorylation of Erk after 
stimulation of human microvascular endothelial cells (HMECs) 
with VEGF-A (Fig. S5 B, available at http://www.jcb.org/cgi/
content/full/jcb.200709127/DC1). Erk was intensively activated 
5  –  15 min after stimulation but not at later time points. These 
fi  ndings indicate that activation of Erk at later time points is not 
a common feature of VEGFR2 signaling. 
  We further examined the farnesylation status of H-Ras after 
treatment with FTI-277 (  Fig. 5 C  ). Nonfarnesylated Ras began to 
increase 3 h after treatment and was constant after 6 h. Consistent 
with this fi  nding, FTI-277 inhibited phosphorylation of Erk 6 h 
after VEGF-A-stimulation (  Fig. 5 D  ). We thus confi  rmed that ac-
tivation of Ras around 6 h after VEGF-A stimulation is sensitive 
to FTI-277. These fi  ndings suggest that activation of the Ras  –  Erk 
pathway 6 – 9 h after stimulation with VEGF-A directs endothelial 
specifi  cation of VEGFR2 
+   progenitor cells. 
  VEGF-A  –  induced Ras activation precedes 
the expression of endothelial markers 
  We next examined the expression of vascular markers over 
time during in vitro differentiation of ESC-derived VEGFR2 
+  
cells by VEGF-A (  Fig. 6 A  ). The expression of the endothelial 
  Figure 5.       Window of time within which Ras 
is speciﬁ  cally activated by VEGF-A.   (A) Time 
course of phosphorylation of Erk 3  –  12 h after 
stimulation with VEGF-A. VEGFR2 
+   cells were 
stimulated with 30 ng/ml VEGF-A and lysed 
at the indicated time. Protein lysates were 
subjected to immunoblot analysis using anti  – 
p-44/42 antibody and anti-Erk antibody. (B) Ras 
activation at 5 min and 6 h after stimulation 
with VEGF-A or PDGF-BB. VEGFR2 
+   cells were 
stimulated with 30 ng/ml VEGF-A or 15 ng/ml 
PDGF-BB. At 5 min and 6 h after stimula-
tion, cells were lysed and 1 mg of lysates 
was subjected to pulldown assay using a Ras 
activation assay kit (top). Residual lysates were 
subjected to immunoblot analysis (bottom three 
panels) using anti-Ras antibody, anti-p44/42 
antibody, and anti-tubulin antibody (loading 
control).     , no ligand control cells; V, VEGF-A  – 
stimulated cells; P, PDGF-BB  –  stimulated cells. (C) Time course of change in ratios of farnesylated and nonfarnesylated H-Ras after addition of FTI-277. 
1   μ  M FTI-277 and 30 ng/ml VEGF-A were added to ESC-derived VEGFR2 
+   cells. At 0, 3, 6, 12, and 24 h after addition, cells were lysed and lysates were 
subjected to immunoblot analysis using anti  –  H-Ras antibody. The top bands correspond to nonfarnesylated H-Ras and the bottom bands to farnesylated 
H-Ras. DMSO was used as vehicle control. Tubulin expression is shown as loading control. (D) Inhibitory effect of FTI-277 on phosphorylation of Erk. At 6 h 
after the addition of 1   μ  M FTI-277 and 30 ng/ml VEGF-A, cells were lysed and lysates were subjected to immunoblot analysis using anti-p44/42 and 
anti-Erk antibodies.     JCB • VOLUME 181 • NUMBER 1 • 2008  138 
endothelial cells, though with low effi  ciency (  Schuh et al., 1999 ). 
The endothelial differentiation observed in vitro may be caused 
by an effect of FGF-2, which was included in the culture me-
dium (  Schuh et al., 1999  ), because we previously found that 
FGF-2 supports endothelial differentiation of ESC-derived 
VEGFR2 
+   cells to a modest extent (  Kano et al., 2005  ). VEGFR2 
signaling thus appears to be a pathway for endothelial specifi  -
cation of biological importance and high effi  ciency. 
  The roles of specifi  c pathways downstream of VEGFR2 in 
mediating cell proliferation and migration have been elucidated. 
Phosphorylation of Y1175 of VEGFR2 leads to phospholipase C  –      
activation, followed by PKC     – mediated  Raf  activation  to 
induce cell proliferation (  Takahashi et al., 2001  ). In contrast, 
phosphorylation of Y951 mediates signaling for cell migration 
and actin stress fi  ber organization through interaction with 
T  cell – specifi  c adaptor (  Matsumoto et al., 2005  ). Phosphorylation 
of Y1214 is also implicated in actin stress fi  ber remodeling 
through the p38 pathway ( Lamalice et al., 2004 ). However, which 
of cells during development. VEGFR2 signaling plays a cen-
tral role in de novo blood vessel formation (vasculogenesis). 
In extraembryonic sites, VEGFR2 signaling is primarily required 
for the formation of blood islands ( Shalaby et al., 1995 ), where 
vascular endothelial cells and hematopoietic cells differentiate 
to form primary plexuses. In the absence of VEGFR2 signal-
ing, VEGFR2 
+   progenitor cells fail to migrate to the extraembry-
onic sites (  Shalaby et al., 1997  ). In the embryo proper, VEGFR2 
signaling is required for endothelial specifi  cation of the vascu-
lar progenitor cells (  Shalaby et al., 1997  ). Potential endothelial 
precursor cells are observed in the correct location where they 
would develop into embryonic blood vessels but fail to complete 
the pathway of differentiation. Recently, shear stress has been 
shown to induce differentiation of endothelial cells from pro-
genitor cells (  Yamamoto et al., 2003  ;   Yamamoto et al., 2005  ), 
which is mediated through ligand-independent activation of 
VEGFR2 (  Yamamoto et al., 2005  ). In embryoid body culture 
system in vitro, however, VEGFR2 
   /     ESCs still give rise to 
  Figure 6.       Expression of vascular mark-
ers over time after in vitro differentiation of 
VEGFR2 
+   cells.   Quantitative RT-PCR analysis 
of vascular markers of cells stimulated with 
30 ng/ml VEGF-A (A) or H-Ras[G12V] (B) in the 
presence of serum. Each value is normalized 
to the expression of GAPDH. Error bars rep-
resent SD.     139  RAS SIGNALING IN ENDOTHELIAL SPECIFICATION   •   KAWASAKI ET AL.
tain signaling molecules. Notably, the delayed activation of Ras 
was not observed in mature endothelial cells, suggesting that it is 
not a common feature of VEGFR2 signaling. 
  In mature endothelial cells, Ras signaling appears to be in-
volved in cell proliferation, tubule formation, and cell survival 
downstream of FGF receptor or integrin    v  ( Klint  et  al.,  1999 ; 
  Hood et al., 2003  ). However, the role of Ras downstream of 
VEGFR2 has been regarded as marginal (  Shibuya and Claesson-
Welsh, 2006  ). The present study is the fi  rst to suggest the crucial 
role of Ras  –  Erk signaling downstream of VEGFR2 in endo-
thelial specifi  cation of vascular progenitor cells. 
  We examined vasculogenesis in allantoic explants ob-
tained from E8.5 embryos and found reduced vascular formation 
in those from H-  ras  
   /     (2 out of 12 embryos), whereas those 
from H-  ras  
+/+   ( n   = 16) or H-  ras  
+/      ( n   = 26) embryos exhibited 
no such phenotype (unpublished data). We also examined vas-
cular formation in H-  ras  
   /     mice and found vascular aberration 
in the periphery of the brain of 73% of E9.5 H-  ras  
   /     embryos. 
However, there was no obvious abnormality of E10.5 H-  ras  
   /    
embryos, which is consistent with the previous results that sug-
gest H-  ras   knockout mice are born and grow normally (  Ise et al., 
2000 ;  Esteban et al., 2001 ). These fi  ndings suggest that H- ras  
   /    
embryos catch up for the delay in vascular formation in cephalic 
region until E10.5. One possibility is that expression of other 
members of the Ras family, N-Ras and K-Ras, is up-regulated 
and compensates for the loss of H-Ras as reported previously 
(  Ise et al., 2000  ). Alternatively, reduction of endothelial differ-
entiation in the absence of H-Ras may be permissive for embry-
onic development although quantitative assay in vitro exhibits 
substantial reduction (  Fig. 1 B   and   Fig. 2 D  ). Compensatory 
growth of differentiated endothelial cells may offset reduction 
in endothelial differentiation. It appears likely that N-Ras 
and K-Ras are also involved in endothelial specifi  cation be-
cause treatment with FTI-277 that principally targets H-Ras or 
knockdown of H-Ras failed to completely inhibit endothelial 
specifi  cation induced by VEGF-A in the in vitro vascular differ-
entiation assay. 
  In summary, we have demonstrated the involvement of Ras 
signaling in VEGFR2-mediated endothelial specifi  cation of vas-
cular progenitor cells and provided novel insights into temporal 
aspects of signaling for cell lineage specifi  cation through widely 
shared effector molecules. 
  Materials and methods 
  Cells and cell culture 
  The CCE ESC line was obtained from M.J. Evans (University of Cambridge, 
Cambridge, UK) and MGZ5 and MGZRTcH ESC cells were obtained from 
H. Niwa (RIKEN Center for Developmental Biology, Kobe, Japan). Mainte-
nance, differentiation, culture, and cell sorting of CCE, MGZ5, and MGZ-
RTcH ESCs were performed as previously described (  Yamashita et al., 
2000  ). For in vitro differentiation, mouse ESCs were cultured on type IV 
collagen-coated dishes in the absence of leukemia inhibitory factor for 4 d. 
VEGFR2 
+   vascular progenitor cells were then sorted and used for analysis 
of endothelial differentiation. We plated 2   ×   10 
4   ESC-derived VEGFR2 
+   
cells per well on type IV collagen-coated 8-well CultureSlides (IWAKI) for 
immunostaining or 0.6  –  1   ×   10 
3   cells per well on 1-well CultureSlides for 
limiting dilution assay. The cells were cultured for 2  –  4 d in       –  minimum 
  essential medium (Invitrogen) supplemented with 10% FBS in the presence 
of the following various ligands or inhibitors: VEGF-A (VEGF165; R  &  D 
Systems), Flt1-Fc chimera proteins (R  &  D Systems), PDGF-BB (PeproTech), 
signaling pathway downstream of VEGFR2 is involved in endo-
thelial specifi  cation has not been elucidated. 
  VEGF-A promotes the differentiation of endothelial cells 
from ESC-derived VEGFR2 
+   cells, whereas PlGF, a specifi  c ligand 
for VEGFR1, fails to induce endothelial differentiation (  Yamashita 
et al., 2000  ). We have also reported that ectopically expressed 
VEGFR3 fails to transmit signal for endothelial differentiation 
of VEGFR2 
+   progenitor cells (  Suzuki et al., 2005  ). These fi  nd-
ings suggest that VEGFR2 has unique features of signal trans-
duction among VEGF receptor family members. In the present 
study, we unexpectedly found that Ras signaling downstream of 
VEGFR2 is involved in specifying endothelial differentiation of 
VEGFR2 
+   vascular progenitor cells. We also found that the 
Raf  –  Erk pathway plays an important role downstream of Ras in 
endothelial specifi  cation. Interestingly, activation of Erk has been 
reported in blood islands of the E7.5 mouse embryo (  Corson 
et al., 2003  ). 
  Ras signaling is known to act as a switch that determines 
cell fate in vulval formation in   Caenorhabditis elegans   ( Sternberg 
and Han, 1998  ) and in photoreceptor development in   Drosophila 
melanogaster   (  Wassarman et al., 1995  ). Ras is, however, activated 
by various extracellular stimuli in mammalian cells. ESC-derived 
VEGFR2 
+  cells are differentiated into endothelial cells by VEGF-A, 
but not by PDGF-BB, although both ligands activate Ras in 
the cells. It will thus be important to determine how VEGFR2 
transmits specifi  c signals using an effector that is widely shared 
among different signaling pathways like Ras. In PC12 cells, EGF 
stimulation results in transient activation of Erk to induce cell 
proliferation, whereas NGF stimulation results in sustained acti-
vation of Erk to cause growth arrest and outgrowth of neurites 
(  Marshall, 1995  ). Similarly, unique utilization of Ras by the 
VEGFR2 system likely accounts for the specifi  c signaling to in-
duce endothelial differentiation. In the present study, we found 
that Ras is specifi  cally activated by VEGF-A around 6  –  9 h after 
stimulation. This delayed activation of Ras appears to transmit 
specifi  c signaling for endothelial differentiation, which is consis-
tent with the time course of FTI-277 sensitivity. 
  Usage of Ras by the VEGFR2 system differs in cells of vari-
ous origins. In human aortic and umbilical vein endothelial cells 
as well as rat sinusoidal endothelial cells, activation of Ras by 
VEGF-A is modest. The PKC-dependent pathway, but not Ras, 
principally transmits the signal for Erk activation (  Doanes et al., 
1999  ;   Takahashi et al., 1999  ;   Yashima et al., 2001  ). In contrast, 
VEGF-A induces intense activation of Ras and Ras-mediated acti-
vation of Erk in HMECs (  Yashima et al., 2001  ). These differential 
signaling properties may refl  ect the unique profi  les of expression 
of signaling molecules in each type of cell. In our experiments us-
ing ESC-derived VEGFR2 
+   progenitor cells, the PKC-dependent 
pathway appeared to be activated in the early phase because phos-
phorylation of Erk was notably increased but activation of Ras 
was modest 5 min after VEGF-A stimulation. In contrast, the Ras 
pathway was strongly activated to induce phosphorylation of Erk 
in the delayed phase (6  –  9 h after stimulation), a fi  nding supported 
by the inhibition of Erk phosphorylation by FTI-277 (  Fig. 5 D  ). 
The mechanism of this delayed activation of Ras remains to be 
elucidated in detail. It is possible that the activation is not direct 
and instead is mediated through transcriptional induction of cer-JCB • VOLUME 181 • NUMBER 1 • 2008  140 
Tc and/or 30 ng/ml VEGF-A, followed by microscopic observation. In some 
of the samples, SU5614 was added. Collagen gels were photographed 
using microscopy (IX70; OLYMPUS) with 10  ×   objectives (UPlanFI; 0.3 NA), 
at room temperature. 
  In vivo vascular formation assay 
  All ESCs were labeled with YFP retrovirus before in vivo vascular formation as-
say to distinguish cells of ESC origin and host origin. ESCs were cultured on 
type IV collagen-coated dishes in the absence of leukemia inhibitory factor 
for 4 d. Then 10 
7   cells were pelleted and mixed with 100   μ  l PBS and 100   μ  l 
Matrigel and injected subcutaneously into the abdominal region of 4-wk-old 
male 129svJ mice. In vivo suppression of transgene was maintained by add-
ing 1   μ  g/ml Tc in Matrigel and supplementing drinking water with 2 mg/ml 
doxycycline. The mice were killed on day 10, and the plaques were harvested 
and ﬁ  xed with formalin. They were then frozen sectioned and stained with 
anti-PECAM1 and     SMA antibodies. Stained sections were photographed us-
ing a confocal microscope (LSM510 META) with 40  ×   oil objectives (Plan-Neo-
ﬂ  uar; 1.3). All images were taken at room temperature. 
  Ras activation assay and immunoblot analysis 
  ESC-derived VEGFR2 
+   cells (6   ×   10 
6  ) were stimulated with 30 ng/ml VEGF-A 
or 15 ng/ml PDGF-BB. Cells were harvested at the indicated time points 
and lysed. The cell lysates were subjected to pulldown assay using Raf-RBD 
(Ras activation assay kit; Millipore). The precipitated GTP-bound Ras was 
detected by anti-Ras antibody. Immunoblot analysis was performed as de-
scribed previously (  Suzuki et al., 2005  ). Image processing and storage 
(TIFF format) was performed using Photoshop software (Adobe). 
  RNA isolation, quantitative RT-PCR, and oligonucleotide microarray 
analysis 
  Culture of VEGFR2 
+   cells with 10% FBS in the absence or presence of 
VEGF-A cells was used as a source of RNA. Total RNA was prepared 
with RNeasy (QIAGEN), according to the manufacturer  ’  s instructions, 
and reverse-transcribed with the SuperScript III ﬁ  rst-strand synthesis sys-
tem (Invitrogen). Expression of various markers of differentiation was 
compared by quantitative RT-PCR analysis. Primer sequences are listed 
in Table S2 (available at http://www.jcb.org/cgi/content/full/jcb
.200709127/DC1). For oligonucleotide microarray analysis, GeneChip 
Mouse Genome 430 2.0 Arrays (Affymetrix) were used according to the 
manufacturer  ’  s instruction. 
  Online supplemental material 
  Fig. S1 shows Tc-regulated inducible expression of premiRNA in ESCs. Fig. S2 
shows Tc-regulated inducible expression of H-Ras[G12V] in ESCs. Fig. S3 
shows effects of pharmacological inhibitors on the induction of PECAM1 
+   
cells and tubule formation by H-Ras[G12V]. Fig. S4 shows Tc-regulated in-
ducible expression of Ras effector mutants in ESCs. Fig. S5 shows time 
course of phosphorylation of Erk in ESC-derived VEGFR2 
+   cells and HMECs 
after ligand stimulation. Table S1 shows genes induced by VEGF-A treat-
ment of ESC-derived VEGFR2 
+   cells for 48 h. Table S2 shows primers used 
in this study. Online supplemental material is available at http://www.jcb
.org/cgi/content/full/jcb.200709127/DC1. 
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